Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cowin Venture

Investor type Angel Group

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 56
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 42
Rounds per year 4.31
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 3
Key employees 4
Stages of investment
Early Stage Venture
Private Equity
Seed

Areas of investment

  • Medical
  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Software
Summary

In 2009 was created Cowin Venture, which is appeared as VC. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.

The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Biotechnology, Interior Design. Among the most popular portfolio startups of the fund, we may highlight GeneCast Biotechnology, Thrive Earlier Detection, Linked-F. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 50 - 100 millions dollars. Considering the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2018. When the investment is from Cowin Venture the average startup value is 100-500 millions dollars. This Cowin Venture works on 15 percentage points less the average amount of lead investments comparing to the other organizations.

We also calculated 4 valuable employees in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Cowin Venture, startups are often financed by Matrix Partners China, SBCVC, Northern Light Venture Capital. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, SBCVC, ZSVC. In the next rounds fund is usually obtained by Matrix Partners China, SBCVC, ZSVC.

Read more

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Degron Therapeutics

$22M09 Jun 2022 Shanghai, Shanghai, China

Supervision Technology

Manufacturing
Optical Communication
$7M12 May 2022 Guangzhou, Guangdong, China

Celsius Therapeutics

Biotechnology
Emergency Medicine
Genetics
Health Care
$83M24 Mar 2022 Cambridge, Massachusetts, United States

Arima Genomics

Biotechnology
Health Care
Medical
$7M15 Mar 2022 San Diego, California, United States

Ucello Therapeutics

Biotechnology
Medical
Pharmaceutical
$25M10 Feb 2022 Chengdu, Sichuan, China

Amberstone Biosciences

Biotechnology
Health Care
Medical
$12M03 Jan 2022 Laguna Hills, California, United States

Amador Bioscience

Biotechnology
$60M30 Dec 2021 Pleasanton, California, United States

Raypaitech

Augmented Reality
Hardware
Software
$1M27 Oct 2021 Hongkou District, China

FORQALY

29 Sep 2021 Shanghai, Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cowin Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: